Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid Oxygen in COPD with Exercise Desaturation
NCT02273830Phase 4Completed
- Sponsor
- J. Tàrrega
- Start
- Sep 2015
- Primary completion
- Oct 2017
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxygen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by J. Tàrrega. Primary endpoint: Health Related Quality of Life at 3 months. Started Sep 2015; status: completed.
02
Drugs
oxygen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02273830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273830.